GlassScriptPhysician profile
Mason D Mccain
NPI 1548779598
$3,038.10
in general payments reported to CMS, 2019-2025
14 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $139 · 2021: $517 · 2022: $504 · 2023: $719 · 2024: $367 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,301 · Entertainment: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.58 |
| Entertainment | $169.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $641.46 | 2021-2025 | Acuvue |
| Optos, INC. | $610.77 | 2020-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $326.91 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $282.24 | 2021-2025 | Precision7, Dailies Total1, Total30 |
| Sun Pharmaceutical Industries INC. | $249.83 | 2023-2024 | Cequa |
| Glaukos Corporation | $239.16 | 2019-2021 | |
| Allergan, INC. | $180.99 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $167.20 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $118.51 | 2019 | |
| Dompe US, INC. | $89.69 | 2025 | Oxervate |
| Biotissue Holdings INC. | $59.30 | 2022-2024 | |
| Abbvie INC. | $41.05 | 2022 | |
| Oyster Point Pharma, INC. | $17.26 | 2022 | |
| Sight Sciences, INC. | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mason Mccain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.